←Back to Expert Scholars
Translational Medicine / 转化医学KRAS Inhibitors, G12C and G12D Resistance
Piro Lito
MD, PhD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Associate Member
45
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Piro Lito is a physician-scientist at MSKCC studying mechanisms of response and resistance to KRAS inhibitors in lung and colorectal cancer. His laboratory has defined adaptive feedback and mutant allele-specific vulnerabilities. He leads early-phase trials of next-generation RAS inhibitors.
Share:
🧪Research Fields 研究领域
KRAS G12C
KRAS G12D
drug resistance
RAS signaling
lung cancer
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Piro Lito 的研究动态
Follow Piro Lito's research updates
留下邮箱，当我们发布与 Piro Lito（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment